Literature DB >> 16013438

LDL induces intracellular signalling and cell migration via atypical LDL-binding protein T-cadherin.

K Rubina1, E Talovskaya, V Cherenkov, D Ivanov, D Stambolsky, T Storozhevykh, V Pinelis, A Shevelev, Ye Parfyonova, T Resink, P Erne, V Tkachuk.   

Abstract

Cadherins are a superfamily of adhesion molecules that mediate Ca(2+)-dependent cell-cell adhesion. T-cadherin (T-cad), a unique glycosylphosphatidylinositol-anchored member of the cadherin superfamily, was initially identified by immunoblotting of vascular cell membranes as an atypical low affinity low density lipoprotein (LDL)-binding protein. It is not known whether this heterophilic interaction is physiologically relevant. Expression of T-cadherin is upregulated in vascular cells during atherosclerosis, restenosis and tumour angiogenesis, conditions characterized by enhanced cell migration and growth. Elevated levels of serum low density lipoproteins (LDL), which result in cholesterol accumulation in vascular wall, is a widely accepted risk factor in atherosclerosis development. Additionally to its metabolic effects, LDL can produce hormone-like effects in a number of cell types. This study has utilized HEK293 cells and L929 cells stably transfected with T-cadherin cDNA to investigate T-cad-dependent responses to LDL. Stable expression of T-cad in both HEK293 and L929 cells results in significantly (p < 0.05) elevated specific surface binding of [I125]-LDL. Compared with mock-transfectants, cells expressing T-cad exhibit significantly (p < 0.01) enhanced LDL-induced mobilization of intracellular Ca(2+)-stores and a significantly (p < 0.01) increased migration toward an LDL gradient (0.1% BSA + 60 microg/ml LDL) in Boyden chamber migration assay. Thus LDL-binding to T-cad is capable of activating physiologically relevant intracellular signaling and functional responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16013438      PMCID: PMC1282457          DOI: 10.1007/s11010-005-0250-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  45 in total

1.  Expression of adhesion molecule T-cadherin is increased during neointima formation in experimental restenosis.

Authors:  Elena Kudrjashova; Pavel Bashtrikov; Valery Bochkov; Yelena Parfyonova; Vsevolod Tkachuk; Julia Antropova; Olga Iljinskaya; Eduard Tararak; Paul Erne; Danila Ivanov; Maria Philippova; Therese J Resink
Journal:  Histochem Cell Biol       Date:  2002-09-27       Impact factor: 4.304

2.  The glycosyl phosphatidylinositol anchor of human T-cadherin binds lipoproteins.

Authors:  T Niermann; F Kern; P Erne; T Resink
Journal:  Biochem Biophys Res Commun       Date:  2000-10-05       Impact factor: 3.575

3.  Expression of cell adhesion molecule T-cadherin in the human vasculature.

Authors:  D Ivanov; M Philippova; J Antropova; F Gubaeva; O Iljinskaya; E Tararak; V Bochkov; P Erne; T Resink; V Tkachuk
Journal:  Histochem Cell Biol       Date:  2001-03       Impact factor: 4.304

4.  Ligand selectivity of 105 kDa and 130 kDa lipoprotein-binding proteins in vascular-smooth-muscle-cell membranes is unique.

Authors:  V N Bochkov; V A Tkachuk; M P Philippova; D V Stambolsky; F R Bühler; T J Resink
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

5.  LDL- and agonist-induced Ca(2+)-mobilization in platelets of healthy subjects and in patients with familial hyperlipoproteinemia type II.

Authors:  V N Bochkov; T A Rozhkova; A A Lyakishev; N A Bochkova; V V Kukharchuk; V A Tkachuk
Journal:  Thromb Res       Date:  1991-02-15       Impact factor: 3.944

6.  Increased expression of H/T-cadherin in tumor-penetrating blood vessels.

Authors:  L Wyder; A Vitaliti; H Schneider; L W Hebbard; D R Moritz; M Wittmer; M Ajmo; R Klemenz
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

7.  Incorporation of leucocyte GPI-anchored proteins and protein tyrosine kinases into lipid-rich membrane domains of COS-7 cells.

Authors:  M Cebecauer; J Cerný; V Horejsí
Journal:  Biochem Biophys Res Commun       Date:  1998-02-24       Impact factor: 3.575

8.  LDL binds to surface-expressed human T-cadherin in transfected HEK293 cells and influences homophilic adhesive interactions.

Authors:  T J Resink; Y S Kuzmenko; F Kern; D Stambolsky; V N Bochkov; V A Tkachuk; P Erne; T Niermann
Journal:  FEBS Lett       Date:  1999-12-10       Impact factor: 4.124

9.  Cell adhesion molecule T-cadherin regulates vascular cell adhesion, phenotype and motility.

Authors:  Danila Ivanov; Maria Philippova; Vsevolod Tkachuk; Paul Erne; Thérèse Resink
Journal:  Exp Cell Res       Date:  2004-02-15       Impact factor: 3.905

10.  T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region.

Authors:  B Ranscht; M T Dours-Zimmermann
Journal:  Neuron       Date:  1991-09       Impact factor: 17.173

View more
  12 in total

1.  PDZ domain-containing 1 (PDZK1) protein regulates phospholipase C-β3 (PLC-β3)-specific activation of somatostatin by forming a ternary complex with PLC-β3 and somatostatin receptors.

Authors:  Jung Kuk Kim; Ohman Kwon; Jinho Kim; Eung-Kyun Kim; Hye Kyung Park; Ji Eun Lee; Kyung Lock Kim; Jung Woong Choi; Seyoung Lim; Heon Seok; Whaseon Lee-Kwon; Jang Hyun Choi; Byoung Heon Kang; Sanguk Kim; Sung Ho Ryu; Pann-Ghill Suh
Journal:  J Biol Chem       Date:  2012-04-23       Impact factor: 5.157

2.  The mouse QTL map helps interpret human genome-wide association studies for HDL cholesterol.

Authors:  Magalie S Leduc; Malcolm Lyons; Katayoon Darvishi; Kenneth Walsh; Susan Sheehan; Sarah Amend; Allison Cox; Marju Orho-Melander; Sekar Kathiresan; Beverly Paigen; Ron Korstanje
Journal:  J Lipid Res       Date:  2011-03-28       Impact factor: 5.922

3.  Urine proteome changes associated with autonomic regulation of heart rate in cosmonauts.

Authors:  Lyudmila H Pastushkova; Vasily B Rusanov; Anna G Goncharova; Alexander G Brzhozovskiy; Alexey S Kononikhin; Anna G Chernikova; Daria N Kashirina; Andrey M Nosovsky; Roman M Baevsky; Evgeny N Nikolaev; Irina M Larina
Journal:  BMC Syst Biol       Date:  2019-03-05

4.  T-cadherin is essential for adiponectin-mediated revascularization.

Authors:  Jennifer L Parker-Duffen; Kazuto Nakamura; Marcy Silver; Ryosuke Kikuchi; Ulrich Tigges; Sumiko Yoshida; Martin S Denzel; Barbara Ranscht; Kenneth Walsh
Journal:  J Biol Chem       Date:  2013-07-03       Impact factor: 5.157

5.  Genetic loci for blood lipid levels identified by linkage and association analyses in Caribbean Hispanics.

Authors:  Chuanhui Dong; Ashley Beecham; Liyong Wang; Susan Slifer; Clinton B Wright; Susan H Blanton; Tatjana Rundek; Ralph L Sacco
Journal:  J Lipid Res       Date:  2011-05-10       Impact factor: 5.922

6.  Pathway-based analysis for genome-wide association studies using supervised principal components.

Authors:  Xi Chen; Lily Wang; Bo Hu; Mingsheng Guo; John Barnard; Xiaofeng Zhu
Journal:  Genet Epidemiol       Date:  2010-11       Impact factor: 2.135

7.  Prognostic significance of CDH13 hypermethylation and mRNA in NSCLC.

Authors:  Ruilin Xue; Cuili Yang; Fang Zhao; Dejia Li
Journal:  Onco Targets Ther       Date:  2014-10-31       Impact factor: 4.147

8.  Clinicopathological significance and potential drug target of T-cadherin in NSCLC.

Authors:  Zhidong Wang; Bin Wang; Huanchen Guo; Guoyu Shi; Xiuqin Hong
Journal:  Drug Des Devel Ther       Date:  2014-12-19       Impact factor: 4.162

9.  Specific electrochemical iodination of horse heart myoglobin at tyrosine 103 as determined by Fourier transform ion cyclotron resonance mass spectrometry.

Authors:  Jesus Iniesta; Helen J Cooper; Alan G Marshall; John Heptinstall; David J Walton; Ian R Peterson
Journal:  Arch Biochem Biophys       Date:  2008-02-29       Impact factor: 4.013

10.  Functional properties of rare missense variants of human CDH13 found in adult attention deficit/hyperactivity disorder (ADHD) patients.

Authors:  Thegna Mavroconstanti; Stefan Johansson; Ingeborg Winge; Per M Knappskog; Jan Haavik
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.